62
Participants
Start Date
May 16, 2018
Primary Completion Date
July 27, 2020
Study Completion Date
July 28, 2020
A4250 (odevixibat)
A4250 is a small molecule and selective inhibitor of ileal bile acid transporter (IBAT).
Placebo
Placebo identical in appearance to active drug (A4250).
Icahn School of Medicine at Mount Sinai, New York
Columbia University Medical Center - Presbyterian Hospital Building, New York
King Faisal Specialist Hospital & Research Centre, Riyadh
Children's Hospital of Pittsburgh, Pittsburgh
Children's Hospital of Philadelphia, Philadelphia
Johns Hopkins School of Medicine, Baltimore
Emory University School of Medicine, Atlanta
Cleveland Clinic, Cleveland
Washington University School of Medicine, St Louis
Baylor College of Medicine - Texas Children's Liver Center, Houston
Children's Hospital Colorado, Denver
Children's Hospital Los Angeles, Los Angeles
University of California, San Francisco, San Francisco
The Royal Children's Hospital, Melbourne
UZ Leuven, Leuven
Cliniques Universitaires Saint-Luc, Woluwe-Saint-Lambert
The Hospital for Sick Children, Toronto
British Columbia Children's Hospital, Vancouver
University and Pediatric Hospital of Lyon, Bron
Universite Paris SUD - Hopitaux Universitaires Paris-Sud - Hopital Bicetre, Le Kremlin-Bicêtre
Hospital de la Timone, Marseille
Hospital Necker-Enfants maladies, Paris
Uniklinikum Essen- Kinderklinik II, Essen
Medizinische Hochschule Hannover, Hanover
Kinderklinik Tübingen, Universitätsklinikum Tübingen, Tübingen
Rambam Medical Centre, Haifa
Shaare-Zedek Mc, Jerusalem
Schneider Children's Medical Center Of Israel, Petah Tikva
Azienda Ospedaliera Papa Giovanni XXIII, Bergamo
University Hospital Of Padova, Padua
Ospedale Regina Margherita, Torino
University Medical Center Groningen, Groningen
Universitair Medisch Centrum (UMC) Utrecht, Utrecht
Instytut Pomnik - Centrum Zdrowia Dziecka, Warsaw
Hospital Universitari Vall d'Hebron, Barcelona
Hospital Universitario La Paz, Madrid
Astrid Lindgren Children's Hospital, Karolinska University Hospital, Solna
Gazi University, Ankara
Hacettepe University Faculty of Medicine, Ankara
Akdeniz University, Antalya
Istanbul University Medical Faculty, Istanbul
Inonu University Medical Faculty, Malatya
Birmingham Women's and Children's NHS Foundation Trust, Birmingham
Leeds General Infirmary, Leeds
Institute of Liver Studies - Kings College Hospital, London
Lead Sponsor
Albireo
INDUSTRY